Grossman Adam S sold ADMA

March 7, 2026 · Form 4 insider transaction

Grossman Adam S sold 29,513 shares of ADMA Biologics, Inc. at $15.39 per share, a transaction worth $454.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
29,513
Price
$15.39
Total value
$454.2K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 7, 2026
Filing dateMarch 10, 2026
Shares owned after2,118,777
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.; Includes, as of the transaction date, (i) 282,529 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 189,017 unvested RSUs out of 252,022 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;; (continued from footnote 2) (iii) 278,864 unvested RSUs out of 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iv) 143,424 unvested RSUs out of 573,695 RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;; (continued from footnote 3) and (v) 1,224,943 shares of common stock owned by the Reporting Person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

View the original Form 4 on SEC EDGAR